PGP and osteosarcoma: We further demonstrated that expression of P-gp can be efficiently blocked by the CRISPR-Cas9 system and inhibition of ABCB1 was associated with reversing drug resistance in osteosarcoma MDR cell lines (KHOSR2 and U-2OSR2) to doxorubicin.